Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

11.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.9K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

3.2K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.2K
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

232
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
232
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

127
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
127
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

248
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
248

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Invasive Blue Crab <i>Callinectes sapidus</i> as a Model for Assessing Sub-Lethal Effects of Polyvinyl Alcohol.

Toxics·2026
Same author

MiR-21 Is a Novel Diagnostic and Prognostic Circulating Biomarker in Pleural Mesothelioma.

Diagnostics (Basel, Switzerland)·2026
Same author

Deep secretome analysis reveals the effects of LiCl on fibroangiogenic remodeling in coculture and mouse models of peritoneal dialysis.

Science signaling·2026
Same author

From cells to tadpoles: mechanistic insights into ZnO-nanoparticle-induced oxidative stress and developmental toxicity in Bufo bufo.

Ecotoxicology (London, England)·2026
Same author

Local Immunometabolic Intervention With Alanyl-Glutamine Resolves Peritoneal Dialysis-Induced Immune Cell Dysfunction.

Kidney international reports·2026
Same author

Coordination of Lipid Storage and Mobilization Pathways During Osteoblast Maturation in a 3D Human Bone Model.

International journal of molecular sciences·2026

Related Experiment Video

Updated: May 5, 2026

Induction of Eryptosis in Red Blood Cells Using a Calcium Ionophore
09:15

Induction of Eryptosis in Red Blood Cells Using a Calcium Ionophore

Published on: January 21, 2020

8.3K

Estramustine-induced suicidal erythrocyte death.

Rosi Bissinger, Paola Modicano, Leonie Frauenfeld

    Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
    |December 4, 2013
    PubMed
    Summary

    Estramustine, used for prostate cancer, may cause anemia by inducing eryptosis, the suicidal death of red blood cells. This study confirms estramustine triggers eryptosis and hemolysis, partly via increased calcium activity.

    More Related Videos

    Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
    04:01

    Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

    Published on: March 15, 2024

    2.1K
    MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data
    07:17

    MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data

    Published on: February 7, 2025

    888

    Related Experiment Videos

    Last Updated: May 5, 2026

    Induction of Eryptosis in Red Blood Cells Using a Calcium Ionophore
    09:15

    Induction of Eryptosis in Red Blood Cells Using a Calcium Ionophore

    Published on: January 21, 2020

    8.3K
    Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
    04:01

    Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

    Published on: March 15, 2024

    2.1K
    MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data
    07:17

    MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data

    Published on: February 7, 2025

    888

    Area of Science:

    • Hematology
    • Oncology
    • Cell Biology

    Background:

    • Estramustine, a nitrogen mustard derivative of estradiol-17β-phosphate, treats prostate cancer.
    • Estramustine may induce cancer cell death and cause anemia as a side effect.
    • Eryptosis, or suicidal erythrocyte death, is characterized by cell shrinkage, increased cytosolic calcium, ceramide formation, and phosphatidylserine exposure.

    Purpose of the Study:

    • To investigate whether estramustine triggers eryptosis.
    • To explore the role of cytosolic calcium activity in estramustine-induced eryptosis.

    Main Methods:

    • Cytosolic calcium activity ([Ca2+]i) was measured using Fluo3 fluorescence.
    • Cell volume was assessed via forward scatter.
    • Phosphatidylserine exposure and hemolysis were quantified by annexin V binding and hemoglobin release, respectively.

    Main Results:

    • Estramustine exposure (≤ 100 μM for 24 h) significantly increased cytosolic calcium activity.
    • Estramustine significantly enhanced phosphatidylserine exposure and hemoglobin release.
    • The effect of estramustine on phosphatidylserine exposure was reduced by removing extracellular calcium.

    Conclusions:

    • Estramustine stimulates both eryptosis and hemolysis in erythrocytes.
    • The observed phosphatidylserine translocation is, at least partially, dependent on increased cytosolic calcium activity.
    • Estramustine's potential to induce anemia may be linked to eryptosis stimulation.